Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (81-90 of 292) with videos related to

Pageof 30
Sort By:
Oncoimmunology|May 12, 2020
Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)Sonja Bergmann, Anja Coym, Leonie Ott, et al.
European Urology|December 5, 2017
Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and MorbidityArmin Soave, Roland Dahlem, Hans O Pinnschmidt, et al.
Urologic Oncology|October 25, 2022
Nephrometry and cumulative morbidity after partial nephrectomy: A standardized assessment of complications in the context of PADUA and R.E.N.A.L. scoresDejan K Filipas, Hang Yu, Clemens Spink, et al.
European Urology|January 1, 2013
Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinomaVitaly Margulis, Shahrokh F Shariat, Yury Rapoport, et al.
Surgical Oncology|March 11, 2019
The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomyPhillip Marks, Philipp Gild, Armin Soave, et al.
Cancer Genetics|May 24, 2014
Reduced membranous MET expression is linked to bladder cancer progressionMartina Kluth, Kristina Reynolds, Michael Rink, et al.
Urologic Oncology|September 21, 2016
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancerAurélie Mbeutcha, Shahrokh F Shariat, Malte Rieken, et al.
Urologia Internationalis|January 9, 2016
Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder CancerGeorgios Gakis, Michael Rink, Hans-Martin Fritsche, et al.
European Urology|May 12, 2012
A review of integrated staging systems for renal cell carcinomaMalek Meskawi, Maxine Sun, Quoc-Dien Trinh, et al.
Urologia Internationalis|February 4, 2024
Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature ReviewAnnemarie Uhlig, Lothar Bergmann, Martin Bögemann, et al.
Pageof 30

Showing results (81-90 of 292) with videos related to

Sort By:
Pageof 30
Oncoimmunology|May 12, 2020
Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)Sonja Bergmann, Anja Coym, Leonie Ott, et al.
European Urology|December 5, 2017
Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and MorbidityArmin Soave, Roland Dahlem, Hans O Pinnschmidt, et al.
Urologic Oncology|October 25, 2022
Nephrometry and cumulative morbidity after partial nephrectomy: A standardized assessment of complications in the context of PADUA and R.E.N.A.L. scoresDejan K Filipas, Hang Yu, Clemens Spink, et al.
European Urology|January 1, 2013
Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinomaVitaly Margulis, Shahrokh F Shariat, Yury Rapoport, et al.
Surgical Oncology|March 11, 2019
The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomyPhillip Marks, Philipp Gild, Armin Soave, et al.
Cancer Genetics|May 24, 2014
Reduced membranous MET expression is linked to bladder cancer progressionMartina Kluth, Kristina Reynolds, Michael Rink, et al.
Urologic Oncology|September 21, 2016
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancerAurélie Mbeutcha, Shahrokh F Shariat, Malte Rieken, et al.
Urologia Internationalis|January 9, 2016
Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder CancerGeorgios Gakis, Michael Rink, Hans-Martin Fritsche, et al.
European Urology|May 12, 2012
A review of integrated staging systems for renal cell carcinomaMalek Meskawi, Maxine Sun, Quoc-Dien Trinh, et al.
Urologia Internationalis|February 4, 2024
Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature ReviewAnnemarie Uhlig, Lothar Bergmann, Martin Bögemann, et al.
Pageof 30